• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification.

作者信息

Carli Giulia, Cecchi Lorenzo, Stebbing Justin, Parronchi Paola, Farsi Alessandro

机构信息

SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, Italy.

Department of Surgery and Cancer, Imperial College London, London, UK.

出版信息

Allergy. 2021 Mar;76(3):955-956. doi: 10.1111/all.14537. Epub 2020 Aug 24.

DOI:10.1111/all.14537
PMID:32830862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7461536/
Abstract
摘要

相似文献

1
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification.COVID-19中的哮喘表型、合并症及疾病活动度：风险分层的必要性
Allergy. 2021 Mar;76(3):955-956. doi: 10.1111/all.14537. Epub 2020 Aug 24.
2
[Prevalence of asthma in patients hospitalized for pneumonia associated to SARS-CoV-2 infection].[因新型冠状病毒肺炎住院患者中哮喘的患病率]
Rev Alerg Mex. 2023 May 24;70(1):1-7. doi: 10.29262/ram.v70i1.1175.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
Asthma in the era of COVID-19.COVID-19 时代的哮喘。
Respir Med. 2023 Nov;218:107373. doi: 10.1016/j.rmed.2023.107373. Epub 2023 Aug 10.
5
Is asthma an exclusionary condition for SARS-CoV-2 infection in China? -the relationship between asthma and COVID-19.哮喘是否是中国 SARS-CoV-2 感染的排除条件？——哮喘与 COVID-19 的关系。
J Asthma. 2021 Oct;58(10):1337-1339. doi: 10.1080/02770903.2020.1789873. Epub 2020 Aug 4.
6
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.RT-PCR 检测的、无需住院的 SARS-CoV-2 感染患者中的哮喘患病率。
Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.
7
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.新型冠状病毒肺炎患者中哮喘表型、相关共病和长期症状。
Allergy. 2022 Jan;77(1):173-185. doi: 10.1111/all.14972. Epub 2021 Jun 19.
8
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
9
Prevalence of comorbid asthma in COVID-19 patients.新冠病毒病患者中合并哮喘的患病率。
J Allergy Clin Immunol. 2020 Aug;146(2):334-335. doi: 10.1016/j.jaci.2020.04.061. Epub 2020 Jun 10.
10
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.

引用本文的文献

1
Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study.患有 COVID-19 的成年哮喘患者的特征与结局：一项比较队列研究。
Qatar Med J. 2023 Aug 8;2023(3):15. doi: 10.5339/qmj.2023.15. eCollection 2023.
2
Long-Term Follow-Up of a Severe Eosinophilic Asthmatic Patient With Comorbid Nasal Polyposis Hospitalized for SARS-CoV-2 Infection While Receiving Benralizumab: A Case Report.1例严重嗜酸性粒细胞性哮喘合并鼻息肉患者在接受贝那利珠单抗治疗期间因感染SARS-CoV-2住院的长期随访：病例报告
Cureus. 2021 Dec 12;13(12):e20364. doi: 10.7759/cureus.20364. eCollection 2021 Dec.
3
Recent advances and developments in COVID-19 in the context of allergic diseases.新冠病毒肺炎在过敏性疾病背景下的最新进展与动态
Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065.
4
Advances and highlights in biomarkers of allergic diseases.过敏性疾病生物标志物的研究进展与亮点。
Allergy. 2021 Dec;76(12):3659-3686. doi: 10.1111/all.15089. Epub 2021 Sep 27.

本文引用的文献

1
Update on asthma prevalence in severe COVID-19 patients.重症 COVID-19 患者哮喘患病率的最新情况。
Allergy. 2021 Mar;76(3):953-954. doi: 10.1111/all.14482. Epub 2020 Jul 22.
2
Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype.SARS-CoV-2 受体 ACE2 的表达和伴随的宿主反应特征因哮喘炎症表型而异。
J Allergy Clin Immunol. 2020 Aug;146(2):315-324.e7. doi: 10.1016/j.jaci.2020.05.051. Epub 2020 Jun 10.
3
Clinical characteristics of COVID-19 patients combined with allergy.新型冠状病毒肺炎合并过敏患者的临床特征
Allergy. 2020 Sep;75(9):2405-2408. doi: 10.1111/all.14434. Epub 2020 Jun 24.
4
Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.新型冠状病毒肺炎重症监护病房患者中支气管哮喘和慢性阻塞性肺疾病的低患病率
Allergy. 2020 Oct;75(10):2703-2704. doi: 10.1111/all.14420. Epub 2020 Jun 12.
5
Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.瑞典严重 COVID-19 的预后因素负担和流行情况。
Eur J Epidemiol. 2020 May;35(5):401-409. doi: 10.1007/s10654-020-00646-z. Epub 2020 May 18.
6
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
7
Asthma.哮喘。
Lancet. 2018 Feb 24;391(10122):783-800. doi: 10.1016/S0140-6736(17)33311-1. Epub 2017 Dec 19.